Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
Open Access
- 29 July 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (30) , e29318
Abstract
Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before September 1, 2018 and searched in Pubmed, Embase, Web of Science, China National Knowledge Infrastructure, WangFang, and Chinese BioMedical databases, STATA 12.0 software was used for statistical analysis, which provides reasonable data and technical support for this article. A total of 10 studies were included in the meta-analysis, including 2652 cancer cases and 3536 rs735482 polymorphic controls. Data were directly extracted from these studies and odds ratios with 95% confidence intervals were computed to estimate the strength of the association. By pooling all eligible studies, the rs735482 polymorphism showed no significant association with susceptibility of several cancers in all the five genetic models (the allelic model: OR = 1.019, 95% CI: 0.916–1.134, P = .731). In addition, another adjusted OR data showed a significant increased risk between the rs735482 and susceptibility of several cancers (the codominant model BB vs AA: OR = 1.353, 95% CI: 1.033–1.774, P = .028) and the stratification analysis by ethnicity indicated the rs735482 is associated with an increased risk of cancer in Chinese group (BB vs AA, OR = 1.391, 95% CI = 1.054–1.837, P = .020; AB+BB vs AA OR = 1.253, 95% CI = 1.011–1.551, P = .039). However, the ERCC1 rs735482 is associated with a decreased risk of cancer in Italian group (AB vs AA, OR = 0.600, 95% CI = 0.402–0.859, P = .012; AB + BB vs AA, OR = 0.620, 95% CI = 0.424–0.908, P = .014). The results of this meta-analysis do not support the association between rs735482 polymorphism and cancer risk. But stratified analysis showed that rs735482 significantly increased the risk of cancer in Chinese while decreased the risk of cancer in Italian. Because of the limited number of samples, larger and well-designed researches are needed to estimate this association in detail.Keywords
This publication has 34 references indexed in Scilit:
- Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese womenGene, 2013
- PPP1R13L variant associated with prognosis for patients with rectal cancerJournal of Cancer Research and Clinical Oncology, 2012
- Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian populationCancer Epidemiology, 2011
- Haplotype frequencies in a sub-region of chromosome 19q13.3, related to risk and prognosis of cancer, differ dramatically between ethnic groupsBMC Medical Genetics, 2009
- MicroRNAs as modulators of smoking-induced gene expression changes in human airway epitheliumProceedings of the National Academy of Sciences, 2009
- A haplotype of polymorphisms in ASE-1, RAI and ERCC1and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a danish prospective case-cohort studyBMC Cancer, 2008
- Polymorphisms of DNA repair genes and risk of non-small cell lung cancerCarcinogenesis, 2005
- Mammalian Overlapping Genes: The Comparative PerspectiveGenome Research, 2004
- CAST, a Novel CD3ε-binding Protein Transducing Activation Signal for Interleukin-2 Production in T CellsJournal of Biological Chemistry, 1999
- Human DNA Repair Excision NucleaseJournal of Biological Chemistry, 1995